NCT01612065

Optimum Misoprostol Dose Prior to Office Hysteroscopy

The Optimum Dose of Vaginal Misoprostol Prior to Office Hysteroscopy: Double Blind Randomized Controlled Trial

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 132 (actual)
• Sponsor: Cairo University · Academic / Other
• Sex: Female
• Age: 18 Years – 55 Years
• Healthy volunteers: Accepted

Summary

Misoprostol is an effective agent for cervical priming before office hysteroscopy, vaginal route is the best, optimum dose not yet known.

Detailed description

The investigators will compare between 2 different doses of vaginal misoprostol, group (1) 200 ug, group (2) 400 ug, 3hours prior to office hysteroscopy , Infertile patient, patients with abnormal bleeding and patient with recurrent abortion Outcome measure: pain score, easiness of the procedure, procedure time, complications

Conditions

• Infertility
• Abnormal Uterine and Vaginal Bleeding, Unspecified
• Recurrent Abortion

Interventions

Type	Name	Description
DRUG	Misoprostol	200 ug
DRUG	Misoprostol	Misoprostol vaginally, 400 ug

Timeline

• Start date: 2012-06-01
• Primary completion: 2013-03-01
• Completion: 2013-04-01
• First posted: 2012-06-05
• Last updated: 2013-04-11

Locations

1 site across 1 country: Egypt